ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Moderna and Carisma collaborate to develop in-vivo engineered CAR-M for oncology
January 11, 2022The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M) therapeutics for the treatment of cancer. -
Carisma Announces FDA Clearance of IND Application for Macrophage Immunotherapy
July 30, 2020Carisma Therapeutics announced the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for the Company's lead product candidate, CT-0508.
Pharma Sources Insight January 2025
